As always, this year's ANA Annual Meeting featured a wide array of groundbreaking research. We're thrilled to share the media coverage that has come out of ANA2020 to date. Please note, many of these publications are behind paywalls, so you'll need a subscription in order to access the articles. Thank you to all the press who covered ANA2020 and to all the researchers who took time out of their busy schedules to speak with the media!
Medscape Medical News
CML Drug Nilotinib Shows Early Effects in Alzheimer's Disease - October 20, 2020
Weight Loss in Obesity May Stall Neuropathy Progress - October 9, 2020
Elsevier Practice Update
Istradefylline as an Adjunct to Levodopa in Parkinson’s Disease - October 17, 2020
New Data on Calcium Channel Modulator for Essential Tremor - October 17, 2020
Corneal Nerve Loss as a Marker for Collateral Circulation in Acute Stroke - October 15, 2020
ANA 2020: Investigational Combination of Rizatriptan and Reformulated Meloxicam Shows Promise in Migraine - October 13, 2020
ANA 2020: Stroke Alerts and Hospitalizations in Urban Centers Declined During the COVID-19 Pandemic - October 13, 2020
ANA 2020: Solriamfetol May Improve Driving Performance in Narcolepsy - October 13, 2020
ANA 2020: Phase II Study Suggests Nilotinib May have Disease Modifying Effects in Alzheimer’s Disease - October 13, 2020
ANA 2020: Studies Support Safety of Calcitonin Gene-Related Peptide Inhibitors for Migraine Treatment - October 13, 2020
ANA 2020: Lack of Advanced Neuroimaging in Acute Ischemic Stroke Means Patients Who Could Benefit From Tissue Plasminogen Activator Are Missed - October 13, 2020
ANA 2020: Small Study Suggests Methylphenidate Does Not Impair Creativity in Adults With Attention Deficit/Hyperactivity Disorders - October 6, 2020
ANA 2020: Polygenic Risk Score Helps Predict Uncontrolled Blood Pressure After Intracranial Hemorrhage - October 06, 2020
ANA 2020: One in Five Neurology Patients Travel Considerable Distances for Care in the United StatesOctober 06, 2020
ANA 2020: Simple Algorithm Helps Neurologists Determine When Patients May Need COVID-19 Testing - October 06, 2020
Healio Neurology
Healio Neurology prepares for ANA2020, first-ever virtual ANA Annual Meeting - October 02, 2020
Study of home visits examines patient characteristics in advanced Parkinson’s disease - October 19, 2020
Medical school curriculum lacks EEG, epilepsy training - October 14, 2020
Very active field’ of research examines glial cells as targets for therapy - October 12, 2020
Patients with epilepsy prefer neurologists manage treatment of anxiety, depression - October 09, 2020
Phenomenal’ session on genomics of personalized medicine reviews range of diseases - October 09, 2020
AXS-07 demonstrates efficacy against migraine in phase 3 trials - October 09, 2020
Migraine interferes with driving ability, reduces driving frequency - October 08, 2020
ART reduces Alzheimer’s prevalence among patients with HIV - October 08, 2020
Role of non-neoplastic brain cells on brain tumor progression - October 07, 2020
Cardiovascular, hematological risk factors impact mortality in pediatric ischemic stroke - October 07, 2020
Higher doses of tanezumab linked to abnormal peripheral sensation vs. NSAIDs in OA - October 06, 2020
1 in 5 patients travel long distances to see a neurologist - October 06, 2020
’Forward-thinking symposium’ highlights use of digital technologies in neurology - October 06, 2020
Patients with MS experience COVID-19 outcomes similar to general population - October 05, 2020
Consultant360/Neurology Learning Network
Michelle Monje, MD, PhD, Discusses the Neuronal Regulation of the Pathobiology of Brain Tumors
Potential Biomarker Identified for Antibody-Mediated Autoimmune Encephalitis
Inflammatory Oligodendrocyte Precursor Cells and Remyelination in MS
Opioid Abuse Disease Burden: Neurological Comorbidities Are an “Underappreciated Contributor”
Predictors of Seizure Identified Among Patients With Inpatient Stroke Codes
Doctor’s Guide/FirstWord Pharm
Solriamfetol Associated with Improved Work Productivity in Patients With Excessive Daytime Sleepiness: Presented at ANA - October 13, 2020
SSRIs Reduce Depression, Improve Language Recovery After Stroke: Presented at ANA - October 14, 2020
Investigational Agent CX-8998 Shows Benefit for Patients With Essential Tremor: Presented at ANA - October 14, 2020
Galcanezumab Effective for Patients Who Have Not Benefited From Commonly Prescribed Migraine Preventive Treatments: Presented at ANA - October 14, 2020